279 filings
8-K
ESPR
Esperion Therapeutics Inc.
8 May 24
Other Events
4:31pm
10-Q
2024 Q1
ESPR
Esperion Therapeutics Inc.
Quarterly report
7 May 24
8:50am
8-K
ESPR
Esperion Therapeutics Inc.
7 May 24
Esperion Reports First Quarter 2024 Financial Results
7:29am
DEF 14A
ESPR
Esperion Therapeutics Inc.
Definitive proxy
11 Apr 24
4:21pm
ARS
2023 FY
ESPR
Esperion Therapeutics Inc.
11 Apr 24
Annual report to shareholders
4:19pm
8-K
nr1ftzkvsy xvpm
27 Feb 24
Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
7:23am
8-K
ctj12t4c2e0f9n4
22 Jan 24
Esperion Announces Proposed Public Offering of Common Stock
6:10am
424B5
pdgdqe
22 Jan 24
Prospectus supplement for primary offering
6:04am
8-K
f3tt9fx
18 Jan 24
Regulation FD Disclosure
4:03pm
424B5
9ig qzzy0exsny
18 Jan 24
Prospectus supplement for primary offering
4:01pm
8-K
aiuy 2e2l
11 Jan 24
Results of Operations and Financial Condition
4:09pm
8-K
8i63q6k3v00euhsidg4
3 Jan 24
Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending Litigation
8:00am
8-K
n5r3ez2v2yh efl
7 Nov 23
Esperion Reports Third Quarter 2023 Financial Results
7:30am
S-8
j30am3funmm
24 Aug 23
Registration of securities for employees
9:29am
S-8
oxix 5dk4s0
1 Aug 23
Registration of securities for employees
9:02am
8-K
qq0 r89qw
1 Aug 23
Esperion Reports Second Quarter 2023 Financial Results
7:07am
8-K
ml4ivs71g 8oa1leeok
26 Jun 23
Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83rd American Diabetes Association Scientific Sessions
6:03am